$BLCM Announces Data Demonstrating Low Rates of Cancer Recurrence in Pediatric AML and ALL Patients Treated with Rivocel ASH18 httpsglobenewswire.comnewsrelease2018120216604180enBellicumAnnouncesDataPresentationatASH2018Demonstrating

$BLCM Announces Data Demonstrating Low Rates of Cancer Recurrence in Pediatric AML and ALL Patients Treated with Rivo-cel #ASH18 https://globenewswire.com/news-release/2018/12/02/1660418/0/en/Bellicum-Announces-Data-Presentation-at-ASH-2018-Demonstrating-

10:32 EST 2 Dec 2018 | Odi Bruckman

$BLCM Announces Data Demonstrating Low Rates of Cancer Recurrence in Pediatric AML and ALL Patients Treated with Rivo-cel #ASH18 https://globenewswire.com/news-release/2018/12/02/1660418/0/en/Bellicum-Announces-Data-Presentation-at-ASH-2018-Demonstrating-Low-Rates-of-Cancer-Recurrence-in-Pediatric-AML-and-ALL-Patients-Treated-with-Rivo-cel.html …

More From BioPortfolio on "$BLCM Announces Data Demonstrating Low Rates of Cancer Recurrence in Pediatric AML and ALL Patients Treated with Rivo-cel #ASH18 https://globenewswire.com/news-release/2018/12/02/1660418/0/en/Bellicum-Announces-Data-Presentation-at-ASH-2018-Demonstrating-"